Moxifloxacin Suppliers & Bulk Manufacturers

Available Forms: Tablets & Opthalmic solution

Available Strengths: Tab- 400 mg; Opthalmic solution- 0.5% (5 mg/mL)

Reference Brands: Avelox®, Avalox®(EU); Avelox®, Vigamox®(US)

Category: Respiratory Disorder

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used for respiratory, sinus, and skin infections. Available in the US and EU as 400 mg tablets, IV infusion, and 0.5% eye drops, it's sold under brands like Avelox® and Vigamox®. Ideal for B2B, PCD, and global pharma markets. Moxifloxacin is available in Tablets & Opthalmic solution and strengths such as Tab- 400 mg; Opthalmic solution- 0.5% (5 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Moxifloxacin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Moxifloxacin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Moxifloxacin is a fourth-generation fluoroquinolone antibiotic used to treat respiratory tract infections, sinusitis, skin infections, and intra-abdominal infections. It is available in the US and EU in multiple forms including 400 mg tablets, 400 mg/250 mL IV infusion, and 0.5% ophthalmic solution. Marketed under brand names such as Avelox®, Avalox®, and Vigamox®, Moxifloxacin is known for its once-daily dosing, excellent tissue penetration, and broad-spectrum antibacterial activity. Widely prescribed for both inpatient and outpatient care, it is a top product for B2B pharma, PCD franchise, and international export, serving as a critical antibiotic in global healthcare supply chains.